Advertisement
U.S. markets open in 3 hours 41 minutes

Taro Pharmaceutical Industries Ltd. (TARO)

NYSE - NYSE Delayed Price. Currency in USD
41.94-0.20 (-0.47%)
At close: 04:00PM EDT
41.94 0.00 (0.00%)
After hours: 05:05PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close42.14
Open42.05
Bid41.50 x 1100
Ask0.00 x 800
Day's Range41.92 - 42.12
52 Week Range22.89 - 45.76
Volume77,288
Avg. Volume56,055
Market Cap1.576B
Beta (5Y Monthly)0.61
PE Ratio (TTM)34.38
EPS (TTM)1.22
Earnings DateMay 21, 2024 - May 27, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 10, 2018
1y Target Est43.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-28% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for TARO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Taro Pharmaceutical Industries
    Weekly Stock ListWe see what we believe are some great opportunities right now in Healthcare -- and we like the sector overall. Argus Director of Research Jim Kelleher, CFA, recently completed his quarterly sector review and raised Healthcare sector to Over-Weight from Market-Weight. The healthcare environment is undergoing rapid transitions, and we now see an unfolding period of significant promise and opportunity. Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 over the past year. The Healthcare sector ETF (XLV) is up 15% over the past year compared to a gain of 31% for the S&P 500. We see opportunity here to pick up some steady companies, with big brands and solid financials. These companies are science-focused and enhance lives. They are innovators. In our list this week, we look across several subsectors within the Healthcare sector and pull out some leaders we like. These stocks also are included in our Focus List and Model Portfolios, as noted below.
    Rating
    Fair Value
    Economic Moat
    22 hours agoArgus Research
View more
  • Bloomberg

    Chemical Linked to Cancer Found in Acne Creams Including Proactiv, Clearasil

    (Bloomberg) -- Hand sanitizers were tainted by benzene. Sunscreens and dry shampoos too. Now acne treatments are joining the list of widely used consumer products found to contain high levels of the chemical linked to cancer.Most Read from BloombergChemical Linked to Cancer Found in Acne Creams Including Proactiv, ClearasilHow Trump’s Ex-Treasury Chief Landed 2024's Highest-Profile US Bank DealNikki Haley Ends 2024 Bid, Setting Up Trump-Biden RematchNew York to Deploy National Guard to NYC Subwa

  • PR Newswire

    Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro

    Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for Taro Pharmaceutical Industries Ltd.

  • Business Wire

    Taro Provides Results for December 31, 2023

    HAWTHORNE, N.Y., January 25, 2024--TARO PROVIDES RESULTS FOR DECEMBER 31, 2023